Psycho‐Oncology最新文献

{"title":"Steroid-Induced Mental Disorders in Oncology Patients: A 10-Year Retrospective Case Series Review.","authors":"Niall Seymour, Muhammad Fahmi Ismail, Kieran Doherty, Ann Bowler, Richard Bambury, Shahid Iqbal, Eugene M Cassidy","doi":"10.1002/pon.70137","DOIUrl":"https://doi.org/10.1002/pon.70137","url":null,"abstract":"<p><strong>Objective: </strong>Patients with cancer are commonly prescribed corticosteroids for a variety of indications. Corticosteroids have long been known to affect mental state. Neuropsychiatric effects range from insomnia, cognitive impairment, and mood symptoms to psychosis and mania. In this study, we aimed to investigate the demographics, steroid exposure, referring indications, symptom profiles, and subsequent treatments of steroid-induced mental disorders in oncology patients.</p><p><strong>Methods: </strong>We conducted a retrospective chart review of patients diagnosed with a steroid-induced mental disorder, as assessed by the psycho-oncology team in Cork University Hospital from 2626 referrals to the service between January 2010 to December 2019.</p><p><strong>Results: </strong>In total, 297 patients had a diagnosis of steroid-induced mental disorder (11% of referrals). 60.6% were female and mean age ± standard deviation (SD) was 57.5 ± 12.9 years. Breast cancer was the most frequent malignancy among females. Haematological cancer was the most frequent among males and the second most frequent among females. The most commonly prescribed steroid was dexamethasone, followed by prednisolone. The median (interquartile range [IQR]) cumulative weekly prednisolone equivalent dose was 186 mg (125-350 mg), with a median (IQR) duration of steroid exposure before symptom onset of 14 (6-47) days. The most frequently recorded symptoms following psychiatric assessment included insomnia, anxiety, and irritability. Psychotropics were commenced in n = 174 (74%) patients, with antipsychotics prescribed to 62.1%. A watchful wait approach was adopted for 25.5% of the patients. 90.2% (n = 185/205) of the patients experienced either complete or partial resolution of the symptoms at their first clinical review.</p><p><strong>Conclusions: </strong>Steroid-induced mental disorders can cause significant comorbidity in patients receiving cancer treatment. The most common symptoms recorded during assessment included insomnia, anxiety, and irritability.</p>","PeriodicalId":20779,"journal":{"name":"Psycho‐Oncology","volume":"34 4","pages":"e70137"},"PeriodicalIF":3.3,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12009012/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144035574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Death Preparedness Scale for Advanced Cancer Patients: Instrument Development and Psychometric Properties.","authors":"Xi Zhang, Xiaoli Wei, Meizhen Zhao, Tieying Zeng, Ye Chen","doi":"10.1002/pon.70149","DOIUrl":"https://doi.org/10.1002/pon.70149","url":null,"abstract":"<p><strong>Purpose: </strong>Death preparedness plays a crucial role in improving the quality of death for advanced cancer patients. However, existing tools only assess certain aspects of death preparedness in advanced cancer patients, and there is limited evidence regarding their reliability and validity. To develop and validate a specific and comprehensive measurement tool for death preparedness in advanced cancer patients.</p><p><strong>Methods: </strong>The scale was developed using an exploratory mixed-methods approach, which included both qualitative and quantitative stages. Grounded theory and existing literature were used to construct a death preparedness scale for advanced cancer patients. Content validity was assessed using the Delphi method. A convenience sampling approach was employed to recruit 753 advanced cancer patients from the oncology wards of six tertiary grade-A general hospitals in Hubei and Anhui provinces, China, for psychometric testing of the scale. Item selection was based on item analysis, exploratory factor analysis was conducted to extract factors, and confirmatory factor analysis was used to assess structural validity.</p><p><strong>Results: </strong>The final scale consists of 4 dimensions and 22 items. These four dimensions are named \"Death awareness,\" \"Emotional response,\" \"Hospice program,\" and \"Reflexive care.\" They explain 64.010% of the total variance. The confirmatory factor analysis (CFA) model showed that the 4-factor model fit the data well. The overall Cronbach's alpha coefficient for the scale was 0.991.</p><p><strong>Conclusion: </strong>The death preparedness scale for advanced cancer patients that we developed demonstrates good reliability and validity, and can be used to comprehensively assess the death preparedness level of advanced cancer patients. Additionally, with the subscale scoring system, healthcare professionals can provide targeted interventions in specific areas of death preparedness for patients, thereby improving both the quality of life and quality of death for advanced cancer patients.</p>","PeriodicalId":20779,"journal":{"name":"Psycho‐Oncology","volume":"34 4","pages":"e70149"},"PeriodicalIF":3.3,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144044813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Combined Treatment With Cognitive Behavioral Therapy for Insomnia and Acceptance and Commitment Therapy Enhances Objective and Subjective Reports of Sleep in Patients With Advanced Cancer.","authors":"Sharla Wells-Di Gregorio, Stacy Flowers, Juan Peng, Donald R Marks, Danielle Probst, Alexandra Zaleta, Don Benson, David E Cohn, Maryam Lustberg, William Carson, Uly Magalang, Sarah Baltimore, Sonia Ancoli-Israel","doi":"10.1002/pon.70141","DOIUrl":"https://doi.org/10.1002/pon.70141","url":null,"abstract":"<p><strong>Background: </strong>Sleep difficulties are common for people with advanced cancer and are associated with poorer mood, lower quality of life, and reduced survival. For these patients, insomnia severity ratings are tied to nighttime awakenings, but little is known about the reasons for awakenings.</p><p><strong>Aims: </strong>This study reports actigraphy sleep outcomes, longitudinal self-reported insomnia severity, and circadian rhythm disruptions from a randomized pilot study comparing a multi-symptom intervention with a wait-list control group for people with advanced cancer.</p><p><strong>Methods: </strong>Twenty-eight people with advanced cancer completed a brief intervention, Finding Our Center Under Stress (FOCUS), designed to enhance sleep and alleviate worry, depression, and fatigue. Participants completed questionnaires and wore an Actiwatch for 7 consecutive 24-h periods pre- and post-intervention.</p><p><strong>Results: </strong>There were no significant group × time actigraphy effects. However, sensitivity analyses with the full intervention sample including the wait-list control arm demonstrated significant effects on actigraphy sleep efficiency, minutes awake after sleep onset (WASO), number of awakenings, naps, and activity at rest. Insomnia severity ratings on the Insomnia Severity Index were maintained longitudinally with 61% meeting the cut-off for insomnia at baseline compared to 18% at 1 year. Participants demonstrated reductions in key reasons for awakenings.</p><p><strong>Conclusions: </strong>Multi-symptom interventions may be necessary for sustained insomnia improvements for people with advanced cancer. The FOCUS intervention is one of the first to demonstrate improvements on self-reported and actigraphic measures of sleep in addition to other symptoms (i.e., worry, uncertainty, depression, fatigue interference, distress) for this population. Future effectiveness studies are warranted given results of this pilot trial.</p><p><strong>Trial registration: </strong>Cognitive-behavioral intervention for worry, uncertainty, and insomnia for cancer survivors (NCT01929720).</p>","PeriodicalId":20779,"journal":{"name":"Psycho‐Oncology","volume":"34 4","pages":"e70141"},"PeriodicalIF":3.3,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11981972/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144014132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cancer-Related Masculine Threat in Young Adult Testicular Cancer Survivors: Associations With Biobehavioral Symptoms.","authors":"Michael A Hoyt, Zixia Wang, Christian J Nelson","doi":"10.1002/pon.70124","DOIUrl":"10.1002/pon.70124","url":null,"abstract":"<p><strong>Objective: </strong>Cancer and cancer treatment have been experienced by some men as a threat to masculinity. Cancer-related masculine threat (CMT) reflects perceptions that cancer and cancer-related change are inconsistent with one's ideal masculine gender role. This secondary analysis examines associations of CMT with symptoms of sleep disturbance, anxiety, and depression, as well as levels of pro-inflammatory biomarkers in young adult men after testicular cancer.</p><p><strong>Methods: </strong>Forty-four young adult men (M age = 28 years; SD = 4.1) who had undergone chemotherapy for testicular cancer within the prior 2 years completed questionnaires and provided blood samples for immune assessments. Patient-reported measures assessed CMT, depressive symptoms, anxiety, and sleep quality.</p><p><strong>Results: </strong>CMT was significantly associated with poorer sleep quality (B = 0.50, p < 0.01), and more symptoms of depression (B = 0.47, p < 0.01) and anxiety (B = 0.54, p < 0.01). CMT was also related to higher circulating levels of IL-6 (B = 0.47, p < 0.05) and CRP (B = 0.33, p < 0.05), but not significantly associated with sTNFαRII.</p><p><strong>Conclusions: </strong>This study provides preliminary evidence for the associations of CMT and biobehavioral symptoms after treatment for testicular cancer. The identification of modifiable processes underpinning such symptoms is crucial to the design of behavioral interventions to reduce and manage persistent symptoms.</p>","PeriodicalId":20779,"journal":{"name":"Psycho‐Oncology","volume":"34 4","pages":"e70124"},"PeriodicalIF":3.3,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11981013/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143803778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Storytelling Through Music With Parents Whose Children Have Died From Cancer: A Randomized Controlled Feasibility Trial.","authors":"Carolyn S Phillips, Sue E Morris, Erin Rodriguez, Heather Woods, Megan Hebdon, Eunju Choi, Jason Morris, Rev Brandon Morgan, Divyangna Moorjani, Joanna Lutrell, Claudia Gruber, Angel Schroder, Deb Umberson, Jun J Mao","doi":"10.1002/pon.70143","DOIUrl":"10.1002/pon.70143","url":null,"abstract":"<p><strong>Background: </strong>Bereaved parents have significantly higher morbidity and mortality than non-bereaved parents. Despite national guidelines recommending bereavement care, resources for bereaved parents are scarce. Most intervention studies lack empirical evidence of effectiveness or alignment with key theoretical concepts.</p><p><strong>Aims: </strong>To evaluate the feasibility of a 6-week intervention with parents of children who have died from cancer. Storytelling Through Music (STM) combines multiple modalities of expression (storytelling, reflective writing, songwriting) and psychoeducation to facilitate loss- and restoration-oriented coping by creating a legacy piece (self-written story paired with a song) to help bereaved parents adapt to a life-long process of finding meaning after loss.</p><p><strong>Methods: </strong>Two-group, randomized controlled trial, utilizing multiple methods. Participants were randomized to STM or waitlist control. The intervention is delivered online and in a group setting. Descriptive statistics were used for feasibility data, content analysis to evaluate open-ended acceptability questions, and RM ANOVA to evaluate the differences between psychosocial, coping, and grief outcomes.</p><p><strong>Results: </strong>Twenty-three parents were enrolled. Average age was (range: 32-68) and the child's average age was 18.9 (range: 1.5-35). This study indicates that the online delivery of STM is feasible and acceptable and provides preliminary evidence of reducing prolonged grief and loneliness.</p><p><strong>Conclusions: </strong>STM is a theoretically driven, innovative approach to addressing grief in a high-risk, underserved population. Findings suggest STM can be delivered online and is acceptable to participants. Adding music to storytelling and reflective writing provides a unique expression and preliminary data suggests improvements in psychosocial well-being, coping, and grief intensity.</p>","PeriodicalId":20779,"journal":{"name":"Psycho‐Oncology","volume":"34 4","pages":"e70143"},"PeriodicalIF":3.3,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143803827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Sensory Processing Sensitivity and Quality of Life Among Cancer Patients and Their Family Caregivers: An Actor-Partner Interdependence Model Analysis.","authors":"Jiao Yang, Yuanxiao Wang, Nan Shen, Ruojia Wu, Yu Xing, Xiaomin Sun, Xudong Xiang, Yanqiu Zhao, Jie Zhou, Qianrong Yang, Hailiang Ran","doi":"10.1002/pon.70121","DOIUrl":"10.1002/pon.70121","url":null,"abstract":"<p><strong>Objective: </strong>Studies report a negative impact of sensory processing sensitivity (SPS) on health outcomes, but evidence from patient-caregiver dyads is scarce. This study aimed to simultaneously examine the independent and interdependent impact of SPS on quality of life (QoL) among cancer patients and their family caregivers.</p><p><strong>Methods: </strong>In this two-stage random sampling cross-sectional study, we conducted a dyadic analysis of data collected from cancer patients and their family caregivers in southwest China. QoL was assessed using the World Health Organization Quality of Life-Brief (WHOQOL-BREF) instrument, and SPS was evaluated using the 10-item Chinese Highly Sensitive Child Scale (CHSC). The actor-partner interdependence model (APIM) was used to examine whether SPS of patients and caregivers was associated with their own and their partner's QoL.</p><p><strong>Results: </strong>Of the 733 dyads included in the analysis, patients' SPS and QoL were significantly correlated with their caregivers' SPS and QoL. The APIM identified significant actor effects, including a negative association between SPS and physical, psychological, social, and environmental QoL in both patients and caregivers. Additionally, caregivers' SPS was negatively associated with patients' psychological (β = -0.12, p < 0.01), social (β = -0.09, p < 0.05), and environmental (β = -0.1, p < 0.01) QoL.</p><p><strong>Conclusion: </strong>The findings emphasize the need for early identification and targeted interventions to support highly sensitive individuals within the cancer care setting. Future research should explore the effectiveness of such interventions in enhancing QoL outcomes.</p>","PeriodicalId":20779,"journal":{"name":"Psycho‐Oncology","volume":"34 3","pages":"e70121"},"PeriodicalIF":3.3,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143582360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Psycho-Oncological Issues in a Pediatric Sample: Two Years Follow-Up Data of Consultation Liaison Psychiatry.","authors":"Ayşegül Efe, Yusuf Selman Çelik, Meryem Kaşak, Şeyma Selcen Macit, Zehra Betül Özdemir, Sidre Nur Karakolcu, Elif Nur Şen, Gülce Solcan, Sibel Maraz, Ahmet Furkan Kaya, Vuslat Sena Yavuz Kaynak, Ülkü Beyza Gökmen, Dilanur Cınbırtoğlu, Reyyan Nazlıgül, Muhammed Coşkun, Berkay Şahin, Yusuf Öztürk","doi":"10.1002/pon.70112","DOIUrl":"10.1002/pon.70112","url":null,"abstract":"<p><strong>Background: </strong>Pediatric oncology patients encounter substantial psychosocial and psychiatric challenges alongside physical illness and treatment burdens. Consultation-Liaison Psychiatry (CLP) is critical for addressing these young patients' mental health needs within a broader healthcare framework. Socioeconomic disparities, family dynamics, and educational interruptions further complicate the psychiatric landscape in pediatric oncology.</p><p><strong>Aims: </strong>This study aims to explore the sociodemographic and psychiatric profiles of pediatric oncology patients referred to CLP services.</p><p><strong>Methods: </strong>A retrospective cross-sectional study was conducted on 97 pediatric oncology patients who received CLP consultations over two years. Data included sociodemographic details, clinical history, and psychiatric diagnoses based on structured clinical interviews. Statistical analyses, including multivariate logistic regression, examined relationships between psychiatric outcomes and variables such as SES, educational status, and clinical factors.</p><p><strong>Results: </strong>The sample was predominantly of low SES (72.2%), with depression, adjustment disorders, and sleep disorders frequently observed. Patients unable to continue formal education due to their oncological disease and treatment process showed higher rates of depression. Significant associations emerged between psychopathology and factors such as lower SES, older parental age, and steroid use, although the predictive strength was modest. Most psychiatric consultations occurred due to observed psychiatric complaints rather than proactive psychosocial support, highlighting a reactive rather than preventive approach in CLP practice.</p><p><strong>Conclusions: </strong>Findings highlight the importance of early, structured psychiatric intervention and a proactive CLP approach to mitigate the psychiatric impact on pediatric oncology patients. Addressing SES-based disparities and supporting educational continuity are essential for holistic pediatric cancer care.</p>","PeriodicalId":20779,"journal":{"name":"Psycho‐Oncology","volume":"34 3","pages":"e70112"},"PeriodicalIF":3.3,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11864917/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143516519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Effects of Biofeedback Intervention on Negative Emotions and Sleep Quality in Children With Leukemia Receiving Invasive Procedures and Their Caregivers: A Randomized Controlled Trial.","authors":"Jing Han, Hong Song, Linlin Wang, Liuna Bi, Feng Yang","doi":"10.1002/pon.70134","DOIUrl":"10.1002/pon.70134","url":null,"abstract":"<p><strong>Objective: </strong>Children with leukemia and their caregivers have negative experiences such as pain, fear, and sleep disturbances when receiving invasive procedures. The purpose of this study was to evaluate the effects of a biofeedback intervention on negative emotions and sleep quality for children with leukemia receiving invasive procedures and their caregivers.</p><p><strong>Methods: </strong>A randomized controlled study involving 80 child-caregiver dyads was conducted, and dyads were randomly assigned to intervention (n = 40) and control (n = 40) groups. Both groups received health education, while the intervention group additionally received a 4-unit biofeedback intervention. Outcome measures compared at baseline (T0), post-intervention (T1), and 4-week follow-up (T2), included validated measures of pain, fear, worry, sleep quality in children, and anxiety, depression, and sleep quality in caregivers.</p><p><strong>Results: </strong>At T1 and T2, the scores of children's pain and fear in the intervention group were significantly lower than those in the control group (all p < 0.05). The significant group effects on children's pain (F = 6.064, p = 0.015) and fear (F = 15.532, p < 0.001) indicated that the intervention group had significantly lower scores in pain and fear compared to the control group. At T1 and T2, caregivers in the intervention group had significantly lower anxiety scores and significantly higher sleep quality than those in the control group (all p < 0.05). The significant group effects on anxiety (F = 10.124, p = 0.002) and sleep quality (F = 5.983, p = 0.015) suggested that the intervention group had significantly lower scores in anxiety and higher sleep quality in comparison to the control group.</p><p><strong>Conclusions: </strong>The biofeedback intervention demonstrated significant efficacy in alleviating the pain, and fear experienced by children with leukemia during invasive procedures, concurrently relieving their caregivers' anxiety and improving sleep quality. This research furnishes compelling evidence substantiating the effectiveness of biofeedback interventions in alleviating negative emotions in children with leukemia undergoing invasive treatments, as well as in their caregivers.</p><p><strong>Trial registration: </strong>ChiCTR2300075306.</p>","PeriodicalId":20779,"journal":{"name":"Psycho‐Oncology","volume":"34 3","pages":"e70134"},"PeriodicalIF":3.3,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143650337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Longitudinal Dyadic Associations in Benefit Finding and in Fear of Cancer Recurrence Between Childhood Cancer Survivors and Their Parents: Examining Actor and Partner Effects.","authors":"Elise Van Laere, Janne Vanderhaegen, Sofie Prikken, Jurgen Lemiere, Anne Uyttebroeck, Koen Luyckx","doi":"10.1002/pon.70113","DOIUrl":"10.1002/pon.70113","url":null,"abstract":"<p><strong>Background and aim: </strong>Childhood cancer survivors and their parents report both positive and negative psychological late effects, such as fear of cancer recurrence (FCR) and benefit finding. The current study investigated longitudinal dyadic associations among childhood cancer survivors, their mothers, and fathers in benefit finding and FCR to obtain an in-depth understanding of family functioning after pediatric cancer.</p><p><strong>Methods: </strong>This three-wave longitudinal study (covering 2 years) included survivors (aged 14-24, time since diagnosis 2-22 years at T1) and their parents; all reported on benefit finding and FCR. Reciprocal effects in three dyads were examined: (1) survivor-mother dyad (n = 114 at T1), (2) survivor-father dyad (n = 82 at T1), and (3) mother-father dyad (n = 80 at T1). Cross-lagged panel models examined actor and partner effects across time for benefit finding and FCR separately.</p><p><strong>Results: </strong>Actor effects were significant in all models. Dyadic partner effects were found between parents. First, mothers' benefit finding predicted relative increases in fathers' benefit finding across both time intervals. Second, mothers' FCR predicted relative increases in fathers' FCR from T1 to T2, and fathers' FCR predicted relative increases in mothers' FCR from T2 to T3. Moreover, significant correlated changes were found between parents' FCR at T2 and T3.</p><p><strong>Conclusion: </strong>Results support substantial actor effects and some dyadic partner effects between parents in experiencing psychological late effects. To improve survivorship care for families, psychological late effects of each family member and their interplay between members-especially among parents-needs to be taken into account, both in research and clinical practice.</p>","PeriodicalId":20779,"journal":{"name":"Psycho‐Oncology","volume":"34 3","pages":"e70113"},"PeriodicalIF":3.3,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143634416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Interventions for Children of Parents With Cancer From the Time of Cancer Diagnosis Through Bereavement: Two Systematic Reviews.","authors":"Paige K Malinowski, Cristina Pozo-Kaderman, Anna C Muriel, Joan Hanania, William F Pirl, Anna Dorste, Chloe Rotman, Greta Jankauskaite, Eileen K Joyce, Sue E Morris","doi":"10.1002/pon.70105","DOIUrl":"10.1002/pon.70105","url":null,"abstract":"<p><strong>Objective: </strong>While there has been increasing attention on caring for children following a parent's cancer diagnosis or death, few studies include scalable evidence-based interventions to facilitate adjustment. The aim of this review was to summarize recent empirical studies that included interventions for minor children (0-18 years) with clear pre- and post-assessments of the child's psychological functioning from the time a parent is diagnosed with cancer through bereavement.</p><p><strong>Methods: </strong>Two separate systematic reviews were conducted for interventions during either a parent's illness or bereavement. We searched Ovid Medline, PsycINFO, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Sociological Abstracts, and Social Services Abstracts for articles published in 2015 and beyond.</p><p><strong>Results: </strong>For the first review, 113 articles were reviewed at the full-text level. Of those, 11 met study inclusion criteria. All were published between 2015-2023 and the sample size ranged from 16-176, including 534 children in total, aged 4-18 years. Thirteen validated measures were used. For the second review, 49 articles were reviewed at the full text level, and only one met criteria. This study, published in 2023, included 20 children aged 7-12 years. Two validated measures were used. Quality assessment indicated a generally low risk of bias and high methodological quality for both reviews.</p><p><strong>Conclusions: </strong>Evidence-based interventions for minor children whose parents have been diagnosed with cancer or who are bereaved during childhood are limited. To standardize and move the field forward, we propose a model to guide the development of interventions for children whose parents have been diagnosed with cancer through bereavement.</p>","PeriodicalId":20779,"journal":{"name":"Psycho‐Oncology","volume":"34 3","pages":"e70105"},"PeriodicalIF":3.3,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143625092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}